OPM-2人骨髓瘤細胞、OPM
- 公司名稱 上海富雨生物科技有限公司
- 品牌
- 型號
- 產地
- 廠商性質 生產廠家
- 更新時間 2025/4/24 14:36:59
- 訪問次數(shù) 74
聯(lián)系方式:陳壽彬18956075901 查看聯(lián)系方式
聯(lián)系我們時請說明是化工儀器網上看到的信息,謝謝!
OPM-2 人骨髓瘤細胞
Catalogue No.: C787
Product Format: a 15 ml centrifuge tube
Culture Properties:懸浮
Complete Growth Medium: 89%1640+10%FBS+1%雙抗
Atmosphere: air, 95%; carbon dioxide (CO2), 5%
Application: Cells and cancer research
NOTE: FOR RESEARCH USE ONLY.
Components
Item | Specifications |
a 15 ml centrifuge tube | 2X106 |
Manual | 1 copy |
191560449-01 (同微-信)
disease after cessation of therapy. Evidence from patients treated with allogenic stem cell transplantation or IFN-α points to an important role of anti-tumor immunity for durable control of CML disease. Data from multiple in vitro and ex vivo studies indicate that BCR-ABL inhibitors may also influence anti-tumor immunity. Varying effects on different immune effector cell suwqts and of the different compounds have been reported, the latter being